Code | 05040 | ||||||||||
MA number | 09/0103/11-S | ||||||||||
Product Form: | tbl ent 14x40 mg (blis.nylon/Al/PVC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Zentiva, k.s., Czechia | ||||||||||
Therapeutic Class: | 09 - ANTACIDA (VRÁTANE ANTIULCEROSNYCH LIEČIV) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 15.02.2011 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
SPC: | SPC_Ozzion 40 mg gastrorezistentné tablety_03_2022.pdf |
PIL: | PIL_Ozzion 40 mg gastrorezistentné tablety_03_2022.pdf |
Safety feature | Yes |
Data update: | 15.05.2019 |